ESR1 and breast cancer: Tamoxifen treatment significantly suppressed tumor growth in MCF7‐shControl cells but not in MCF7‐shMIR497HG cells (Figure 4L,M, Supporting Information), demonstrating that MIR497HG depletion reduced tamoxifen sensitivity in ER+ breast cancer cells.